KR880000091A - 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 - Google Patents
국소용 약제학적 조성물 이의 제조방법 및 이의 용도 Download PDFInfo
- Publication number
- KR880000091A KR880000091A KR870005609A KR870005609A KR880000091A KR 880000091 A KR880000091 A KR 880000091A KR 870005609 A KR870005609 A KR 870005609A KR 870005609 A KR870005609 A KR 870005609A KR 880000091 A KR880000091 A KR 880000091A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- active ingredient
- composition according
- pharmaceutically acceptable
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 통상의 약제학적 보조제와 함께, 활성 성분으로서 하기구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중의 하나를 함유함을 특징으로 하는, 국소용, 즉 피부용 약제학적 조성물.
- 제 1 항에 있어서, 크림제, 연고제, 지방성 연고제, 페이스트, 겔제, 포움제, 팅크제, 용액제 또는 점안제 형태인 약제학적 조성물.
- 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중의 하나를, 특히 제 1 항 또는 2 항에 따르는 약제학적 조성물의 형태로, 국소적으로, 즉 피부에 적용함을 특징으로 하여, 염증성 피부 질환을 치료하는 방법.
- 염증성 피부 질환을 국소적, 즉 피부적으로 치료하기 위한, 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중 하나의 용도.
- 염증성 피부 질환을 국소적, 즉 피부적으로 치료하도록 의도면 피부과용 약제학적 조성물을 제조하기 위한, 하기 구조식(I)의 화합물 또는 이의 약제학적으로 허용되는 염중 하나의 용도.
- 활성 성분으로 2-하이드록시-5-[(RS)-1하이드록시-2-[[(RS)-1-(P-메톡시페닐)-프로프-2-일]-아미노]-에틸]-포름아닐라이드(포름오테롤) 또는 이의 약제학적으로 허용되는 염이 선택됨을 특징으로 하는, 제 1 항 또는 2 항에 따르는 약제학적 조성물, 제 3 항에 따르는 치료 방법 및 제 4 항 또는 5 항에 따르는 용도.
- 활성 성분으로서 2-하이드록시-5-[(RS)-1하이드록시-2-[[(RS)-1-(P-메톡시페닐)-프로프-2-일]-아미노]-에틸]-포름아닐라이드(포름오테롤) 또는 이의 세미푸마레이트가 선택됨을 특징으로 하는, 제 1 항 또는 제 2 항에 따르는 약제학적 조성물, 제 3 항에 따르는 치료방법 및 제 4 항 또는 5 항에 따르는 용도.
- 활성 성분의 이율이 대략 0.00001 내지 1중량 %임을 특징으로 하는, 제 1,2,6 및 7항 중 어느 한항에 따르는 약제학적 조성물, 제 3,6 및 7항 중 어느 한 항에 따르는 치료방법 및 제 4 내지 7항중 어느 한 항에 따르는 용도.
- 활성 성분의 비율이 대략 0.0005 내지 0.5중량 %임을 특징으로 하는, 제 1,2,6 및 7항 중 어느 한항에 따르는 약제학적 조성물, 제 3,6 및 7항중 어느 한 항에 따르는 치료 방법 및 제 4 내지 7항 중 어느 한 항에 따르는 용도.
- 제 3,6 및 7 항중 어느 한 항에 있어서, 치료할 피부 부위를 1일 2 또는 3회 치료함을 특징으로하는 치료 방법.
- 제 1,2 및 6내지 9항 중 어느 한 항에 있어서, 실시예 1내지 9에 기술된 바와 같은 약제학적 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH229086 | 1986-06-05 | ||
CH2290/86-4 | 1986-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880000091A true KR880000091A (ko) | 1988-03-23 |
Family
ID=4230316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870005609A KR880000091A (ko) | 1986-06-05 | 1987-06-03 | 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 |
Country Status (10)
Country | Link |
---|---|
US (1) | US4975466A (ko) |
EP (1) | EP0252286B1 (ko) |
JP (1) | JPS6322015A (ko) |
KR (1) | KR880000091A (ko) |
AU (1) | AU614712B2 (ko) |
CA (1) | CA1305423C (ko) |
DE (1) | DE3780226D1 (ko) |
DK (1) | DK167841B1 (ko) |
IE (1) | IE59612B1 (ko) |
PH (1) | PH25150A (ko) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03178929A (ja) * | 1989-09-07 | 1991-08-02 | Glaxo Group Ltd | 炎症及びアレルギー治療用化合物 |
US5434304A (en) * | 1990-09-26 | 1995-07-18 | Aktiebolaget Astra | Process for preparing formoterol and related compounds |
US6866839B2 (en) * | 1991-04-05 | 2005-03-15 | Sepracor Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
US6299863B1 (en) | 1992-04-03 | 2001-10-09 | Sepracor Inc. | Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy |
US5135954A (en) * | 1991-05-24 | 1992-08-04 | The Regents Of The University Of California | Use of formoterol for treatment of tissue injury |
DK0872246T3 (da) * | 1995-11-30 | 2003-06-10 | Kissei Pharmaceutical | Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis |
WO1998014184A1 (fr) * | 1996-10-04 | 1998-04-09 | Saitama Daiichi Seiyaku Kabushiki Kaisha | Timbre percutane |
US6319464B1 (en) | 1996-12-13 | 2001-11-20 | Alcon Manufacturing, Ltd. | Use of low molecular weight amino alcohols in ophthalmic compositions |
US6303145B2 (en) | 1999-05-10 | 2001-10-16 | Sepracor Inc. | (S,R) formoterol methods and compositions |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
JP2006505583A (ja) | 2002-10-25 | 2006-02-16 | フォーミックス エルティーディー. | 化粧剤および医薬用フォーム |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9211259B2 (en) * | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
JP5108234B2 (ja) * | 2005-02-07 | 2012-12-26 | 日本特殊陶業株式会社 | マイクロヒータ及びセンサ |
RS51464B (en) | 2005-04-13 | 2011-04-30 | Astion Development A/S | BETA-2 ADRENOCEPTOR AGONISTS FOR TREATMENT OF DISEASES OF THE SKIN TISSUE TISSUE |
CA2659095C (en) * | 2006-07-14 | 2015-04-28 | Stiefel Research Australia Pty Ltd | Fatty acid pharmaceutical foam |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009090558A2 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
WO2010091274A1 (en) * | 2009-02-06 | 2010-08-12 | Skinvisible Pharmaceuticals, Inc. | A cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011039638A2 (en) | 2009-10-02 | 2011-04-07 | Foamix Ltd. | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2366625C2 (ko) * | 1972-02-05 | 1988-06-09 | Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp | |
US3994974A (en) * | 1972-02-05 | 1976-11-30 | Yamanouchi Pharmaceutical Co., Ltd. | α-Aminomethylbenzyl alcohol derivatives |
DE2401450A1 (de) * | 1973-01-16 | 1974-07-18 | John James Voorhees | Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen |
GB1531718A (en) * | 1974-11-20 | 1978-11-08 | Pharmacia As | Phenylethanolamines |
DK31578A (da) * | 1977-02-03 | 1978-08-04 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af benzenderivater |
JPS5592312A (en) * | 1978-12-29 | 1980-07-12 | Yamanouchi Pharmaceut Co Ltd | Suppository containing bronchodilating compound |
US4303637A (en) * | 1980-04-04 | 1981-12-01 | Alza Corporation | Medication indicated for ocular hypertension |
JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
JPS60174716A (ja) * | 1984-02-21 | 1985-09-09 | Yamanouchi Pharmaceut Co Ltd | パツチ剤 |
-
1987
- 1987-05-29 PH PH35328A patent/PH25150A/en unknown
- 1987-06-02 DE DE8787107958T patent/DE3780226D1/de not_active Expired - Lifetime
- 1987-06-02 EP EP87107958A patent/EP0252286B1/de not_active Expired - Lifetime
- 1987-06-03 CA CA000538656A patent/CA1305423C/en not_active Expired - Lifetime
- 1987-06-03 KR KR870005609A patent/KR880000091A/ko not_active Application Discontinuation
- 1987-06-04 DK DK289487A patent/DK167841B1/da not_active IP Right Cessation
- 1987-06-04 JP JP62139076A patent/JPS6322015A/ja active Granted
- 1987-06-04 AU AU73836/87A patent/AU614712B2/en not_active Ceased
- 1987-06-04 IE IE148587A patent/IE59612B1/en not_active IP Right Cessation
-
1988
- 1988-12-07 US US07/282,928 patent/US4975466A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0252286A2 (de) | 1988-01-13 |
EP0252286B1 (de) | 1992-07-08 |
IE59612B1 (en) | 1994-03-09 |
IE871485L (en) | 1987-12-05 |
JPH0448774B2 (ko) | 1992-08-07 |
PH25150A (en) | 1991-03-13 |
AU7383687A (en) | 1987-12-10 |
JPS6322015A (ja) | 1988-01-29 |
CA1305423C (en) | 1992-07-21 |
EP0252286A3 (en) | 1990-01-17 |
DE3780226D1 (de) | 1992-08-13 |
DK289487A (da) | 1987-12-06 |
US4975466A (en) | 1990-12-04 |
DK167841B1 (da) | 1993-12-27 |
AU614712B2 (en) | 1991-09-12 |
DK289487D0 (da) | 1987-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880000091A (ko) | 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 | |
JP2668800B2 (ja) | 皮膚疾患の局所治療 | |
US4296130A (en) | Methylsulfonylmethane and methods of use | |
US4607101A (en) | Method of treating acne vulgaris with a composition containing carbamide peroxide | |
US4477469A (en) | Preparations containing methylsulfonylmethane and methods of use and purification | |
US4301145A (en) | Antiseptic skin cream | |
KR960000855A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물 | |
JPS611623A (ja) | 局所薬および全身薬の皮膚および膜を介する透過促進組成物およびその方法 | |
KR900017590A (ko) | 좌창(Acne)치료방법 및 그 약제 조성물 | |
KR950000142A (ko) | 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도 | |
KR960010002A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
DK284386D0 (da) | Farmaceutisk praeparat mod hudlidelser | |
US6465514B1 (en) | Methods and compositions for the promotion of hair growth | |
US3663716A (en) | Method of treating acne with benzyl alcohol | |
US4518583A (en) | Hemorrhoid and anorectal disease treatment method | |
US5176918A (en) | Topical medicament | |
KR950000141A (ko) | 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도 | |
KR960010003A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
KR880007068A (ko) | 13-시스 레티노산의 용도 | |
KR920700627A (ko) | 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도 | |
IE810489L (en) | Composition for topical application | |
RU2005122466A (ru) | Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат | |
US4994497A (en) | Method of avoiding or minimizing burn damage to the skin | |
JPS60152415A (ja) | 外用挫瘡治療剤 | |
KR930701976A (ko) | 알칸 아미도 암모늄 화합물의 신규용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |